Get started Log in

SLNCF — Silence Therapeutics Share News

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapMomentum Trap

Market Cap
$902.88m
Enterprise Value
$830.82m
Revenue
$0.56m

Silence Therapeutics - Holding(s) in Company
10/11/2021 07:00
Silence Therapeutics - New Key Shareholder
05/11/2021 06:59
Silence Therapeutics - Result of General Meeting
01/11/2021 17:33
Silence Therapeutics - Total Voting Rights
01/11/2021 16:49
Silence Therapeutics - Holding(s) in Company
28/10/2021 16:02
Silence Therapeutics - Silence Provides Pipeline Updates at 2021 R&D Day
21/10/2021 13:30
Brief: Silence Therapeutics PLC Files For Offering Of Up To $300 Mln Ordinary Shares
15/10/2021 14:41
Brief: Silence Therapeutics And Hansoh Pharma Announces Collaboration
15/10/2021 07:20
Silence Therapeutics - Proposed Cancellation of Trading on AIM
15/10/2021 07:05
Silence Therapeutics - Silence and Hansoh Pharma Announce Collaboration
15/10/2021 07:00
Brief: Hansoh Pharmaceutical Entered Exclusive License & Collaboration Agreement With Silence Therapeutics
15/10/2021 02:48
Silence Therapeutics - Block Listing Return
08/10/2021 07:00
Silence Therapeutics - Total Voting Rights
08/10/2021 07:00
Silence Therapeutics - Silence Therapeutics to host R&D day
07/10/2021 07:00
Silence Therapeutics - Chardan Genetic Medicines Conference Participation
28/09/2021 06:59
Silence Therapeutics - Holding(s) in Company
08/09/2021 16:03
Silence Therapeutics - Holding(s) in Company
08/09/2021 16:00
Silence Therapeutics - Silence Appoints Senior VP of BD, AM and NPD.
01/09/2021 07:00
Silence Therapeutics - Silence to Participate in Investor Conferences
25/08/2021 07:00
Silence Therapeutics - Silence Therapeutics Report Half-Year 2021 Results
12/08/2021 07:00